Company Filing History:
6 out of 48 
4 out of 30 
4 out of 193 
Years Active: 1997-2015
Title: Steven M Torkelson: Innovator in Pharmaceutical Inventions
Introduction
Steven M Torkelson is a prominent inventor based in San Mateo, CA, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio that includes 10 patents, Torkelson's work primarily focuses on developing innovative inhibitors for various factors that play crucial roles in thromboembolic disorders and other serious health conditions.
Latest Patents
Torkelson's latest patents demonstrate his commitment to advancing medical science. His inventions include novel inhibitors targeting Factors VIIa, IXa, Xa, and XIa, specifically emphasizing Factor VIIa. These pharmaceutical compositions have the potential to treat or prevent thromboembolic disorders, cancer, or rheumatoid arthritis. Furthermore, his patents also detail processes for preparing these crucial inhibitors and highlight the active compounds such as 2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives, which function as Factor VIIa inhibitors.
Career Highlights
Throughout his career, Steven has worked with esteemed companies in the industry, including Systemix, Inc. and Prolinx Incorporated. His experiences at these organizations have undoubtedly contributed to his innovative approach to developing pharmaceutical solutions.
Collaborations
Steven has collaborated with talented individuals during his professional journey. Notably, he has worked alongside Robert J. Kaiser and Kevin P. Lund, sharing ideas and expertise that have enhanced his inventive process and contributed to his notable achievements.
Conclusion
Steven M Torkelson stands out as a noteworthy inventor whose work has the potential to impact the pharmaceutical landscape significantly. His dedication to developing novel therapeutic solutions reflects his innovative spirit and commitment to addressing pressing health challenges. As he continues to work on pioneering projects, the implications of his patents will serve to benefit both the medical community and patients worldwide.